Cargando…
A peptide-based assay discriminates individual antibody response to SARS-CoV-2
SARS-CoV-2 virus is responsible for the current worldwide coronavirus disease 2019 (COVID-19) pandemic, infecting millions of people and causing hundreds of thousands of deaths. Understanding the antibody response to SARS-CoV-2 is crucial for the development of vaccines, therapeutics and public heal...
Autores principales: | Polvere, Immacolata, Voccola, Serena, Cardinale, Gaetano, Fumi, Maurizio, Aquila, Francesca, Parrella, Alfredina, Madera, Jessica Raffaella, Stilo, Romania, Vito, Pasquale, Zotti, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862034/ https://www.ncbi.nlm.nih.gov/pubmed/33564711 http://dx.doi.org/10.1016/j.gendis.2021.01.008 |
Ejemplares similares
-
A Peptide-Based Assay Discriminates Individual Antibody Response to the COVID-19 Pfizer/BioNTech mRNA Vaccine
por: Polvere, Immacolata, et al.
Publicado: (2021) -
Humoral Immune Response Diversity to Different COVID-19 Vaccines: Implications for the “Green Pass” Policy
por: Polvere, Immacolata, et al.
Publicado: (2022) -
Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy
por: Polvere, Immacolata, et al.
Publicado: (2021) -
CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders
por: Zotti, Tiziana, et al.
Publicado: (2018) -
Evaluation of FAST COVID-19 SARS-CoV-2 Antigen Rapid Test Kit for Detection of SARS-CoV-2 in Respiratory Samples from Mildly Symptomatic or Asymptomatic Patients
por: Polvere, Immacolata, et al.
Publicado: (2022)